{
    "clinical_study": {
        "@rank": "70498", 
        "arm_group": [
            {
                "arm_group_label": "Succinylcholine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient received succinylcholine as a muscle relaxant(0.5 mg /kg)for induction of anaesthesia for rigid bronchoscopy."
            }, 
            {
                "arm_group_label": "Rocuronium/Sugammadex", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient received rocuronium (0.25 mg/ kg) as muscle relaxant for induction of anaesthesia for rigid bronchoscopy, at the end of procedure rocuronium was reversed with sugammadex (0.5mg/kg.)"
            }, 
            {
                "arm_group_label": "Rocuronium", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients received rocuronium (0.25 mg /kg)as muscle relaxant for induction of anaesthesia for rigid bronchoscopy."
            }
        ], 
        "brief_summary": {
            "textblock": "Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as\n      rigid bronchoscopy. A more modern alternative is the application of low-dose rocuronium,\n      reversed by low-dose sugammadex. The investigators compare the intubating conditions,\n      incidence of postoperative myalgia (POM), as well as patient satisfaction for these two\n      muscle relaxants."
        }, 
        "brief_title": "Muscle Relaxation for Short Procedures", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Intubating Conditions", 
            "Fasciculations", 
            "Postoperative Myalgia", 
            "Patient Satisfaction", 
            "Sore Throat"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fasciculation", 
                "Pharyngitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 18 yr\n\n          -  scheduled for elective rigid bronchoscopy\n\n        Exclusion Criteria:\n\n          -  known neuromuscular disease\n\n          -  significant hepatic or renal dysfunction\n\n          -  family history of malignant hyperthermia\n\n          -  known allergy to one of the drugs used in this protocol\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01902641", 
            "org_study_id": "HSK001", 
            "secondary_id": "2011_333N-MA"
        }, 
        "intervention": [
            {
                "arm_group_label": "Succinylcholine", 
                "description": "Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 \u00b5g/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received succinycholine according to the study group.", 
                "intervention_name": "Succinylcholine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Rocuronium/Sugammadex", 
                "description": "Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 \u00b5g/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received rocuronium/sugammadex according to the study group.", 
                "intervention_name": "Rocuronium/Sugammadex", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Rocuronium", 
                "description": "Anaesthesia was induced and maintained with propofol (1-2 mg/kg) and remifentanil (0.5 \u00b5g/kg). The study arm was immobilized and a dual electrode for peripheral nerve stimulation was placed over the ulnar nerve near the wrist. Neuromuscular monitoring was performed with accelerometry.The patients received rocuronium according to the study group.", 
                "intervention_name": "Rocuronium", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Succinylcholine", 
                "Rocuronium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "succinylcholine", 
            "rocuronium", 
            "sugammadex", 
            "Intubating Conditions", 
            "short Procedures"
        ], 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wiesbaden", 
                    "country": "Germany", 
                    "zip": "65199"
                }, 
                "name": "Dr. Horst Schmidt Kliniken"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparing Intubating Conditions and Patient Satisfaction Using Succinylcholine or Low-dose Rocuronium for Rigid Bronchoscopy: A Randomized Study", 
        "other_outcome": [
            {
                "description": "Measurement on an numeric ten point scale, the patients receive a questionaire", 
                "measure": "Sore throat", 
                "safety_issue": "No", 
                "time_frame": "72 hours after intervention"
            }, 
            {
                "description": "Measurement on a numeric ten point scale the patients receive a questionaire", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "72 Hours after intervention"
            }
        ], 
        "overall_official": {
            "affiliation": "Dr. Horst Schmidt Kliniken Wiesbaden Germany", 
            "last_name": "Grietje Beck, Prof", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "scoring system proposed for Good Clinical Research Practice using the following variables: conditions of inserting rigid bronchoscope, vocal cord position, and coughing", 
            "measure": "Intubating condition", 
            "safety_issue": "No", 
            "time_frame": "After induction of general anaesthesia (after 3-5 minutes)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01902641"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Fasciculations were graded by the investigator on the following four-point scale\n0 = no fasciculations\n= mild, fine fasciculations of the eyes, neck, face or fingers, without limb movement\n= moderate fasciculations occurring at more than two sites, or obvious limb movement\n= vigorous or severe, sustained and widespread fasciculations in the trunk and limbs", 
                "measure": "Fasciculations", 
                "safety_issue": "No", 
                "time_frame": "After application of the neuromuscular blocking agent (after 3-5 min)"
            }, 
            {
                "description": "The severity of POM was measured using a four-point scale 0 = no myalgia\n= minor pain limited to one area of the body\n= muscle pain or stiffness noticed spontaneously by the patient, which may have required analgesic therapy\n= generalized, severe, or incapacitating discomfort", 
                "measure": "Postoperative Myalgia (POM)", 
                "safety_issue": "No", 
                "time_frame": "72 Hours after Intervention"
            }
        ], 
        "source": "Dr. Horst Schmidt Klinik GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Horst Schmidt Klinik GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}